Pub. L. 115-31, div. F, tit. III (as amended)

302.The Chief Medical Officer shall submit a report to the Committees on Appropriations of the Senate and the House of Representatives that includes—(1)a comprehensive strategy and project plan to advance the Nation’s early detection capabilities related to a bioterrorism event;(2)a description of the responsibilities of the Office of Health Affairs, Science and Technology Directorate, and other departmental components as appropriate for implementing such strategy;(3)a description of technical and operational programmatic efficiencies to be gained by replacing or enhancing the current BioWatch system;(4)specific timelines and benchmarks for implementation of a new or enhanced system, including, but not limited to—(A)a mission needs statement;(B)operational requirements documents;(C)key performance parameters;(D)a test and evaluation master plan; and(E)an acquisition plan and strategy;(5)an expenditure plan for fiscal year 2017 activities that advance the Nation’s early detection capabilities related to a bioterrorism event; and(6)detailed cost estimates for not less than 5 years for the development of a new or enhanced BioWatch system.